Twitter LinkedIn
    Wednesday, July 6
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»Eurazeo increases stake in VC firm Kurma Partners
    Deals

    Eurazeo increases stake in VC firm Kurma Partners

    September 24, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Eurazeo is to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology and medical innovation, to 70.6 per cent.

    This transaction coincides with Kurma’s launch of a third investment strategy, Growth Opportunity, to support more mature companies, with late stage clinical or early commercial stage asset, in which Eurazeo will be a leading investor.

    With nearly EUR500 million in assets under management and more than 45 investments made since its launch in 2009, Kurma Partners has built up strong and widely recognised expertise in the financing of innovation in the health care sector and in biotechnology, from pre-seed to growth capital, through its Kurma Biofund and Kurma Diagnostics funds. Its team of 13 investors is managed by five partners with more than 15 years of experience as investors in the health care sector.

    Along with this increased stake, Eurazeo is set to become a leading investor in the funds managed by Kurma Partners, particularly in support of the launch of its new crossover investment strategy to accompany the most promising European companies, with products having reached more advanced stages of development. To accelerate Kurma’s growth trajectory, Eurazeo plans to commit nearly EUR100 million to its funds. Eurazeo will also be providing operational support, together with access to its international network, to help Kurma Partners become a European leader in the area of Life Sciences innovation. Kurma Partners will retain its management independence and its existing team.

    Read more/Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Inflexion leads SteriPack buyout

    July 6, 2022

    Barings and Partners Group provide financing to support Arcline’s CoreDux acquisition

    July 6, 2022

    Brookfield pours record US$12B into European deals

    July 6, 2022

    £15bn KKR-led Power Networks takeover ‘collapses over price increase’

    July 6, 2022

    Comments are closed.

    Other Articles

    GlobalWafers raises takeover bid for Siltronic to $5.1 billion

    January 22, 2021

    Banks Ready Sale of $10 Billion Debt for McAfee Leveraged Buyout

    January 20, 2022

    Commonfund Capital closes third co-investment fund at USD160m

    August 26, 2021

    Dechert expands private equity practice with new London Partner

    May 20, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?